• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

As U.S. Treasury intervened in the bond market, the Netherlands rushed 86 tons of gold out of America because of ‘geopolitical unrest’

2

'Critical employees will begin to retire': Trump’s new pay plan will deny most federal roles a raise, and it has workers warning of a retention crunch

3

One of MacKenzie Scott's latest donations takes her HBCU giving to well over $1 billion

1

As U.S. Treasury intervened in the bond market, the Netherlands rushed 86 tons of gold out of America because of ‘geopolitical unrest’

2

'Critical employees will begin to retire': Trump’s new pay plan will deny most federal roles a raise, and it has workers warning of a retention crunch

3

One of MacKenzie Scott's latest donations takes her HBCU giving to well over $1 billion
Health

White House: There’s no money to pay for everyone’s fourth COVID shot

By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
March 22, 2022, 12:13 PM ET
Google source logo
Add Fortune on Google for similar content.

While medical officials debate whether a second COVID-19 booster shot is necessary, Biden administration officials are warning that the government doesn’t have the money to pay for those doses, as it did the first vaccination rounds.

White House coronavirus coordinator Jeff Zients, in an upcoming podcast, said: “Right now, we don’t have enough money for fourth doses, if they’re called for. We don’t have the funding, if we were to need a variant-specific vaccine in the future.” The quote was reported by The Washington Post.

Pfizer and Moderna have both filed for emergency authorization for a second COVID-19 booster shot for people 65 and older – this would mean a third or fourth round of jabs, depending on the vaccines you’ve had previously.

A decision on those applications could come as early as next month.

But while there’s adequate funding for seniors, as well as children under age 5 (should those vaccinations receive approval), there’s not enough money to pay for other age groups, if the second booster is suggested for a wider set of people.

Officials say they can’t place any more orders until Congress passes a stalled $15 billion funding bill.

A study by Israel’s health ministry in January found that a fourth COVID shot had twice the protection from infection as the others, and at least three times the protection from severe illness.

Israel began administering a fourth dose to older adults, health workers and people with compromised immune systems in late December.

Health officials say the government would need to purchase about 750 million doses to be able to provide a fourth dose to everyone.

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.

About the Author
By Chris MorrisFormer Contributing Writer

Chris Morris is a former contributing writer at Fortune, covering everything from general business news to the video game and theme park industries.

See full bioRight Arrow Button Icon
Google source logo
Add Fortune on Google for similar content.

Latest in Health


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Latest in Health


    Most Popular

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.